Sara Cabodi

5PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 24, 2019
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.

Andrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini

|Mar 01, 2019
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.

Andrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini

|Nov 05, 2018
Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation.

Maria Del Pilar Camacho Leal, Andrea Costamagna, Beatrice Tassone

|Apr 27, 2017
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.

Marianna Sciortino, Maria Del Pilar Camacho-Leal, Francesca Orso

|Mar 17, 2017
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

Silvia Grasso, Jennifer Chapelle, Vincenzo Salemme

Pageof 1